Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-T Cell Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04272125
What this trial is testing

Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute
Chongqing Precision Biotech Co., Ltd 40
Early research (Phase 1)Active Not RecruitingNCT03186118
What this trial is testing

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

Who this might be right for
CD 19+ Acute Leukemia
Seattle Children's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Not applicableUnknownNCT06509490
What this trial is testing

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Who this might be right for
Safety Issues
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 9
Testing effectiveness (Phase 2)UnknownNCT03525782
What this trial is testing

Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC

Who this might be right for
Lung Neoplasm MalignantNon-small Cell Lung Cancer
The First Affiliated Hospital of Guangdong Pharmaceutical University 60
Early research (Phase 1)Study completedNCT03019055
What this trial is testing

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, B-CellChronic Lymphocytic Leukemia+1 more
Medical College of Wisconsin 26
Testing effectiveness (Phase 2)UnknownNCT03366350
What this trial is testing

Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 50
Testing effectiveness (Phase 2)Looking for participantsNCT07148791
What this trial is testing

Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

Who this might be right for
IgG4 Related DiseaseB-cell Mediated Autoimmune Disorders
Chinese PLA General Hospital 9
Testing effectiveness (Phase 2)Study completedNCT03289455
What this trial is testing

CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRefractory Childhood Acute Lymphoblastic Leukemia+1 more
Autolus Limited 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04697940
What this trial is testing

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

Who this might be right for
Relapsed and Refractory B-cell Non-Hodgkin's LymphomaDecitabine-primed Tandem CD19/CD20 CAR T Cells
Han weidong 33
Not applicableActive Not RecruitingNCT07101913
What this trial is testing

Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.

Who this might be right for
Acute Kidney Injury (AKI)Infusion of CD19 CAR T CellB Cell Lymphoma
Hospices Civils de Lyon 300
Not applicableUnknownNCT03488160
What this trial is testing

CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma

Who this might be right for
Lymphoma
Sinobioway Cell Therapy Co., Ltd. 6
Not applicableLooking for participantsNCT07236203
What this trial is testing

Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study

Who this might be right for
Large B-Cell Lymphoma
Fudan University 80
Not applicableLooking for participantsNCT06389305
What this trial is testing

CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid Leukemia
Beijing GoBroad Hospital 213
Early research (Phase 1)Active Not RecruitingNCT06222853
What this trial is testing

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusCAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine 22
Not applicableNot Yet RecruitingNCT06906380
What this trial is testing

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, in Relapsed or RefractoryMDS (Myelodysplastic Syndrome)
ARCE Therapeutics, Inc. 49
Early research (Phase 1)Looking for participantsNCT06622694
What this trial is testing

CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia

Who this might be right for
Severe Aplastic AnemiaRelapseRefractory+1 more
Institute of Hematology & Blood Diseases Hospital, China 15
Early research (Phase 1)Not Yet RecruitingNCT07500805
What this trial is testing

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Who this might be right for
CD70-positive Advanced Renal Clear Cell Carcinoma
UTC Therapeutics Inc. 21
Early research (Phase 1)WithdrawnNCT04094766
What this trial is testing

Safety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic Leukemia

Who this might be right for
Refractory B Acute Lymphoblastic LeukemiaRelapse B Acute Lymphoblastic Leukemia
Second Affiliated Hospital of Xi'an Jiaotong University
Testing effectiveness (Phase 2)UnknownNCT05164042
What this trial is testing

Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapse LeukemiaRefractory Leukemia
Shenzhen University General Hospital 20
Next Page